Rabab M. Gaafar
Kasr El Aini Street, Fom El Khalig Square
Cairo, C 11796, Egypt
Cairo, C 11796, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus.
Journal: Journal of the Egyptian National Cancer Institute
Published: June 09, 2022
Real-World Data on the Prevalence of Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer in the Middle East and North Africa.
Journal: JCO global oncology
Published: November 17, 2021
Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa - KINDLE Study.
Journal: Clinical lung cancer
Published: November 10, 2021
Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients.
Journal: Journal of the Egyptian National Cancer Institute
Published: August 23, 2021
Risk factors for inflammatory and non-inflammatory breast cancer in North Africa.
Journal: Breast cancer research and treatment
Published: December 24, 2019
Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study.
Journal: Lung cancer management
Published: December 07, 2019
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
Journal: Breast cancer research and treatment
Published: April 02, 2019
Lung Cancer in the Middle East and North Africa Region.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 15, 2019
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: November 19, 2018
Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy.
Journal: Clinical pharmacology in drug development
Published: June 20, 2018
Contributing factors to the outcome of primary malignant chest wall tumors.
Journal: Journal of thoracic disease
Published: January 10, 2018
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.
Journal: The Lancet. Oncology
Published: December 21, 2017
Last Updated: 09/26/2026